Looks like the fund managers left their run too late. If Sarepta...

Looks like the fund managers left their run too late. If Sarepta takes out a licensing deal or acquires 1102 for DMD this will go to 50 cents plus in minutes.. so they are raising 500M? If that is an up front payment to acquire 1102 for DMD our market cap goes 5 times ($1 plus) and provides funding for trials on other indications and 1103 for Acromegaly. As ITSA has said in the past, ANP will become a major biotech player with cash backing.. that will even impress AKKI.. by the way where is he now with his gloom and doom. lol still hoping for a 14 cent re entry.. GLTA